We are an independent, private, family-owned business solely focused on giving pharmaceutical companies objective, impartial advice on how to accelerate patient access to important medical therapies.
With NDA our clients work with a single partner linking science, medicine, regulation and reimbursement considerations to optimise development timelines. Our experts supported the development of the regulatory and reimbursement systems in place today.
NDA has no clinical research arm and therefore no interest in driving unnecessary clinical research – we only focus on what you need and what the regulators and payers require.
LSX is an influential community of senior life science decision makers.
We connect senior life science executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.